The Effectiveness and Safety Analysis of Duloxetine in Treating Comorbid Depression in Parkinson's Disease: A Retrospective Study
Duloxetine is associated with superior efficacy in improving motor and non-motor symptoms, overall clinical status, and cognitive function. These findings support the potential utility of duloxetine as a comprehensive treatment option for comorbid depression in Parkinson's disease.
Authors
- Jing Tian (ORCID: https://orcid.org/0000-0003-2055-4281)
- Jianglin Wang (ORCID: https://orcid.org/0000-0002-0733-2097)
- Zhan-Yu Li (ORCID: https://orcid.org/0009-0003-2563-7550)
- Zhuoqun Wang (ORCID: https://orcid.org/0000-0003-1839-8419)
- Na Zhang (ORCID: https://orcid.org/0000-0001-5290-4798)
- Weixin Dai
Institutions
- Jilin Province Tumor Hospital (CN)
- Yanbian University Hospital (CN)
Publication Details
- Journal
- Actas Españolas de Psiquiatría
- Published
- 2024-10-05
- DOI
- https://doi.org/10.62641/aep.v52i5.1634
- Citations
- 5
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.85